Artiva Biotherapeutics, Inc. (ARTV) Total liabilities 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) total liabilities at each fiscal year-end, per SEC filings.
$21.0MFY2025 · since FY2023: $50.7M → $21.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $21.0M | -8.6% |
| FY2024 | $22.9M | -54.8% |
| FY2023 | $50.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARTV financial trends
ARTV RevenueARTV Net incomeARTV Net marginARTV Gross profitARTV Gross marginARTV Operating incomeARTV Operating marginARTV Operating cash flowARTV Free cash flowARTV Capital expendituresARTV Return on equityARTV Stock buybacksARTV Dividends paidARTV Total assetsARTV Shareholders’ equityARTV overview →